Purchases and Sales Made in Q3 2022 in Verona Pharma PLC (VRNA)
This table provides information about the institutional ownership of Verona Pharma PLC (VRNA) during Q3 2022. The information is specifically focused on institutions that hold shares of Verona Pharma plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-297- 17.71% |
$1.23K - $4.04K
|
1.38K
$64.3K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.57K- 73.99% |
$6.51K - $21.4K
|
553
$25.8K
|
|
Nov 07, 2022
Q3 2022
|
D.A. Davidson & Co.
|
SELL
|
- |
-4.5K- 10.11% |
$18.6K - $61.2K
|
40K
$1.86M
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-4.81K- 49.13% |
$19.9K - $65.3K
|
4.98K
$232K
|
|
Nov 14, 2022
Q3 2022
|
Forefront Analytics, LLC
West Conshohocken, PA |
SELL
|
- |
-13.8K- 50.56% |
$56.9K - $187K
|
13.4K
$626K
|
|
Nov 14, 2022
Q3 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-126K- 25.21% |
$523K - $1.72M
|
375K
$17.5M
|
|
Nov 14, 2022
Q3 2022
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-172K- 15.5% |
$713K - $2.34M
|
939K
$43.7M
|